MOTS-c mitochondrial-derived peptide mtDNA AMPK metabolic longevity research Durham Peptides Canada MOTS-c is one of the most conceptually interesting compounds in metabolic and longevity research, for a reason that sets it apart from nearly every other peptide: it isn't encoded by the cell's main DNA. MOTS-c is a mitochondrial-derived peptide — encoded within the small, separate genome of the mitochondria themselves. That unusual origin places it at the intersection of mitoc

Healing recovery peptides tissue repair angiogenesis cell migration BPC-157 TB-500 research Durham Peptides Canada "Recovery peptides" is one of the most popular categories in research peptides — and one of the most loosely defined. The compounds grouped under the label are studied for tissue repair, but they reach that goal through genuinely different mechanisms: building blood supply, mobilizing repair cells, and modulating the genes that govern regeneration. Understanding

TB-500 thymosin beta-4 fragment actin cell migration tissue repair research peptide Durham Peptides Canada TB-500 is the other half of the most-studied recovery peptide pairing in research. Where BPC-157 is studied primarily for building blood supply, TB-500 is studied for a different and complementary function: getting the repair cells to the site of injury. As a synthetic fragment of the naturally occurring protein Thymosin Beta-4, TB-500 sits at the center of cell-migratio

BPC-157 body protection compound angiogenesis tissue repair research peptide Durham Peptides Canada BPC-157 is one of the most-discussed research peptides in the world, and the reason is its breadth: across a large preclinical literature, it has been studied for tissue-repair effects spanning tendon, ligament, muscle, gut, and vascular models — a range unusual for a single compound. That versatility, combined with a robust body of animal research, has made BPC-157 a cornersto

CagriSema vs tirzepatide vs retatrutide metabolic peptide comparison Durham Peptides Canada These three compounds represent the cutting edge of metabolic peptide research — but they reach that frontier by two fundamentally different routes. CagriSema combines two separate molecules (an amylin analog plus a GLP-1 agonist). Tirzepatide and retatrutide are single molecules engineered to hit multiple receptors at once. Understanding that architectural difference — multi-molecule

Semax ACTH 4-10 analog nootropic neuroprotection BDNF research peptide Durham Peptides Canada Most of the attention in research peptides goes to metabolic and tissue-repair compounds — but there's a distinct and rapidly growing category that gets far less coverage: nootropic and neuroprotective research peptides. Semax sits at the center of it. As a synthetic analog of a fragment of adrenocorticotropic hormone (ACTH), modified for stability, Semax has been studied for decades

Epithalon Epitalon tetrapeptide telomere telomerase longevity research Durham Peptides Canada Of all the compounds in longevity research, few target the aging process as directly as Epithalon. Where most longevity compounds work on energy metabolism or cellular signaling, Epithalon is studied at the level of the chromosome itself — specifically the telomeres, the protective caps whose shortening is one of the recognized hallmarks of cellular aging. That direct connection to t

CagriSema cagrilintide semaglutide combination amylin GLP-1 research Durham Peptides Canada CagriSema is one of the most closely watched investigational compounds in modern metabolic research — and one of the clearest examples of where the field is heading. Rather than refining a single incretin pathway, it combines two different mechanisms in one fixed-dose formulation: an amylin analog (cagrilintide) and a GLP-1 receptor agonist (semaglutide). The result is a combination st

AOD-9604 vs semaglutide vs tirzepatide metabolic research peptide comparison Durham Peptides Canada These three compounds get grouped together in searches because they're all studied in the context of fat metabolism — but mechanistically, they could hardly be more different. AOD-9604 is a growth-hormone fragment studied for direct lipolysis. Semaglutide and tirzepatide are incretin peptides that act on entirely different receptors to influence appetite, insulin secretion, and

AOD-9604 HGH fragment 176-191 lipolysis adipose research peptide Durham Peptides Canada AOD-9604 is one of the more interesting molecules in metabolic peptide research because of the question that produced it: can you isolate the fat-metabolism effects of growth hormone without the rest of growth hormone's biology? Full-length human growth hormone (hGH) affects lipolysis, but it also drives IGF-1 production, influences glucose metabolism, and has broad somatotropic (growth-pr

Growth hormone secretagogues GHRH analogs GHRPs ghrelin mimetics research Durham Peptides Canada "Growth hormone secretagogue" is an umbrella term, and the confusion in the peptide research space comes from treating it as one category when it's really several. A secretagogue is simply any compound that stimulates the secretion of growth hormone — but the compounds grouped under that label work through fundamentally different mechanisms, target different receptors, and produce

CJC-1295 vs Ipamorelin GHRH analog ghrelin agonist comparison Durham Peptides Canada "CJC-1295 vs Ipamorelin" is a common search, but it frames the two compounds as competitors when, in research practice, they're collaborators. They act on different receptors, through different pathways, with different effects on the growth-hormone pulse — which is precisely why they're so often studied together rather than chosen one over the other. Understanding the difference between them

CJC-1295 Ipamorelin blend dual pathway growth hormone research peptide Durham Peptides Canada The CJC-1295 + Ipamorelin blend is the single most-studied growth-hormone secretagogue combination in peptide research, and the logic behind it is elegant: rather than pushing one lever of growth-hormone release harder, it pulls two complementary levers at once. By pairing a GHRH-analog (CJC-1295) with a selective ghrelin-receptor agonist (Ipamorelin), the blend engages the two disti

NAD+ vs NMN vs NR comparison NAD-boosting compounds research Durham Peptides Canada "NAD+ vs NMN vs NR" is one of the most common comparison searches in longevity research, and the confusion is understandable: all three are closely related molecules in the same biosynthetic pathway, all three are studied for raising cellular NAD+, and all three are marketed under overlapping "NAD-boosting" language. But they are not interchangeable — they sit at different points in the pathwa

NAD+ nicotinamide adenine dinucleotide coenzyme longevity research Durham Peptides Canada Few molecules sit closer to the center of cellular biology than NAD+. Nicotinamide adenine dinucleotide is a coenzyme present in every living cell, and it participates in more than 500 enzymatic reactions — from the energy-generating pathways that keep cells alive to the repair systems that protect the genome. Over the past two decades, NAD+ has moved from a textbook footnote in metaboli

Tesamorelin vs CJC-1295 vs sermorelin GHRH analog comparison Durham Peptides Canada Three of the most-discussed GHRH analogs in research peptide contexts — tesamorelin, CJC-1295, and sermorelin — share the same fundamental mechanism (GHRH receptor agonism) but differ substantially in structural features, half-life, and research properties. For Canadian researchers entering growth hormone research, understanding these differences is foundational for selecting the appropriate c

Difference between GLOW and KLOW peptide blends comparison Durham Peptides Canada The most common question Canadian researchers ask about Durham Peptides' two flagship combination formulations: what's the actual difference between GLOW Blend and KLOW Blend? The two products have similar names, overlap substantially in composition, and address related research applications. But there are specific differences — one peptide more in KLOW, one additional mechanism, and specific re

Peptide half life meaning definition explained Durham Peptides Canada "Half-life" is one of the most commonly used pharmacokinetic terms in research peptide discussions — and one of the most commonly misunderstood. For Canadian researchers planning research protocols, understanding what peptide half-life actually means (not just the number associated with each peptide) determines how research administration frequency is selected, how clearance is interpreted, and how steady-s

Peptide manufacturing process step-by-step SPPS production Durham Peptides Canada The peptide manufacturing process — from individual amino acid building blocks to a finished research-grade vial — involves multiple distinct production stages, each with its own quality requirements and analytical verification. For Canadian researchers selecting research peptide suppliers, understanding the manufacturing process matters because the quality of the finished vial is determined ent

GHK-Cu TNF-alpha IL-6 NF-kB anti-inflammatory research Durham Peptides Canada Among GHK-Cu's many documented research mechanisms, the anti-inflammatory effects involving TNF-α (tumor necrosis factor alpha), IL-6 (interleukin-6), and NF-κB (nuclear factor kappa-B) signaling have particular relevance to inflammation research. These three molecular players — TNF-α, IL-6, NF-κB — represent central nodes in inflammatory biology, and GHK-Cu's documented effects on each have been st